can you mix sermorelin and ipamorelin & Peptide Therapy

The phenotypic outcome is a shift toward higher energy expenditure and improved adipose/lipid profiles without the catabolic loss of lean tissue commonly seen with severe caloric restriction

The compound is currently in Phase 3 evaluation under the TRIUMPH program, which spans registrational trials in obesity, obstructive sleep apnea, and knee osteoarthritis (PMID 41090431)

Treatment recommendations are individualized and require medical evaluation

doi:10.1038/s41580-020-00313-x Dongoran RA, Mardiana M, Huang CY, Situmorang JH

This binding stimulates the release of growth hormone (GH) in a pulsatile manner, meaning that GH is released in bursts rather than continuously

Matasic, D